知镜 Cognispect · 医学文献与研究工作台

Metabolic acidosis and alkali therapy in paediatric kidney transplant recipients.

Prytuła A.
Pediatric nephrology (Berlin, Germany) · 2026-10-28 · PMID 42955331

文献摘要

Metabolic acidosis is prevalent in up to 40% of paediatric kidney transplant recipients, in the presence of largely restored kidney function. Despite widespread alkali use, a substantial proportion of treated patients do not achieve the biochemical target, reflecting distinct underlying mechanisms. The benefit of metabolic acidosis correction is plausible, yet high quality data supporting alkali use are lacking. Registry-based evidence demonstrates that metabolic acidosis is independently associated with an increased risk of allograft dysfunction, and persistent acidosis despite alkali use is associated with an inferior outcome. This review makes a case for a patient-centred, proportionate alkali prescribing approach. It describes potential causes of poor metabolic acidosis control despite treatment, including under-dosing, type IV renal tubular acidosis, and non-adherence. A proportionate prescribing framework, informed by metabolic acidosis phenotype, adherence assessment, and dose-response, enables maximum benefit in patients who can respond and therapy simplification in those who cannot.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。